Dr. Robert Wood expressed enthusiasm for the new drug but emphasized essential concerns, stating, "We’re very excited about this development but we do have serious concerns," highlighting the lack of studies on its effectiveness during anaphylactic shock.
The FDA recently approved a nasal spray called Neffy, an alternative to EpiPen, but allergists are hesitant due to the absence of clinical studies showing effectiveness in life-threatening allergic reactions.
[
Collection
]
[
|
...
]